Data Disclosure - Applied Clinical Trials

Consensus is rapidly building around the idea that greater access to patient-level clinical data is a good thing – good for science, business and humanity. This paper discusses different approaches to successfully implementing clinical trial data transparency while mitigating the risks. LEARN MORE

This white paper has been designed to provide general information about ClinGenuity’s Artificial Intelligence engine and Clinical Redaction Management Services for Pharmaceutical Transparency and Disclosure Initiatives. LEARN MORE


Clinical Data Disclosure
and Transparency

January 28-29, 2015 | Philadelphia, Pennsylvania

CBI’s successful inaugural event focusing on Clinical Data Disclosure and Transparency is back for its second year! This conference is the biggest of its kind and brings together high level executives to discuss and disseminate aspects of required data disclosure in a time of industry reform. Facing heightened pressure from the EMA, NIH, EFPIA, PhRMA and ICMJE to disclose clinical trial results and be transparent about all clinical trial data, this program focuses on the implications of and approaches being taken for data sharing, ensuring compliance with regulations, navigating disclosure requirements and releasing patient-level data.

More Info

More Events

Interested in being a Data Disclosure and Transparency sponsor? Please contact your Applied Clinical Trials representative for more details.

Wayne Blow Sales Director
T: 44-1244-629 304
F: 44-1925-732 798
wblow@advanstar.com
Laurie Marinone
East Coast Sales Manager
T: 508.808.4723
lmarinone@advanstar.com
Bill Campbell
Regional Sales Manager
Midwest, Southwest and West Coast
T: 847.283.0129
F: 847.282.1456
wcampbell@advanstar.com
Untitled Document

Click here